Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies: This is an Observational Study Aimed at Shedding Light on Women's Health

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
EndometriosisInfertilityEndometrial CancerAdenomyosis, Endometriosis
Interventions
OTHER

No Intervention: Observational Cohort

No interventions will be performed specifically for this study. Samples will be collected from menstrual fluid naturally shed or from biopsies and/or operations that are already taking place.

Sponsors
All Listed Sponsors
lead

Cycle Therapeutics Ltd

INDUSTRY

NCT06990971 - Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies: This is an Observational Study Aimed at Shedding Light on Women's Health | Biotech Hunter | Biotech Hunter